Victory Capital Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.3M | Buy |
354,116
+102,270
| +41% | +$1.53M | ﹤0.01% | 1302 |
|
|
2025
Q1 | $4.06M | Sell |
251,846
-16,230
| -6% | -$262K | ﹤0.01% | 1345 |
|
|
2024
Q4 | $6.24M | Buy |
+268,076
| New | +$6.24M | 0.01% | 1213 |
|
|
2020
Q2 | – | Sell |
-343
| Closed | -$40K | – | 3211 |
|
|
2020
Q1 | $40K | Buy |
+343
| New | +$40K | ﹤0.01% | 2859 |
|
|
2019
Q4 | – | Sell |
-189
| Closed | -$36K | – | 3218 |
|
|
2019
Q3 | $36K | Buy |
+189
| New | +$36K | ﹤0.01% | 2825 |
|